STRUCTURAL STUDIES OF INTERACTIONS AMONG BCL-2 FAMILY PROTEINS

BCL-2 家族蛋白之间相互作用的结构研究

• 批准号: 8361625
• 负责人: AMY E KEATING
• 金额: $ 0.16万
• 依托单位: CORNELL UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-04-01 至 2012-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8361625
• 关键词: Antineoplastic Agents; Apoptotic; BCL1 Oncogene; Binding; Computing Methodologies; Development; Drug Delivery Systems; Drug Design; Family member; Funding; Grant; Human; Ligands; National Center for Research Resources; Peptides; Principal Investigator; Protein Family; Proteins; Research; Research Infrastructure; Resources; Roentgen Rays; Source; Specificity; Structure; United States National Institutes of Health; Work; cost; insight; novel therapeutics; receptor; small molecule; structural biology

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Research in the Keating lab aims to understand determinants of interaction specificity among human Bcl-2 family proteins. The Bcl-2 proteins regulate apoptotis and have emerged as important anti-cancer drug targets. We are studying the binding of short alpha-helical peptides derived from the BH3 region of pro-apoptotic Bcl-2 proteins to anti-apoptotic family members. We carry out binding studies and structural studies and combine these with computational methods to obtain a better understanding of how sequence determines interaction specificity. X-ray crystallographic studies are a key component of this work, as structure provides insights into how the receptor proteins can adjust to bind a range of different ligands. Because new structural snapshots can provide opportunities for peptide or small-molecule drug design, these studies have implications for the development of new therapeutics and diagnotics.

该副本是利用资源的众多研究子项目之一 由NIH/NCRR资助的中心赠款提供。对该子弹的主要支持 而且，副投影的主要研究员可能是其他来源提供的 包括其他NIH来源。 列出的总费用可能 代表subproject使用的中心基础架构的估计量， NCRR赠款不直接向子弹或副本人员提供的直接资金。 基廷实验室中的研究旨在了解人Bcl-2家族蛋白之间相互作用特异性的决定因素。 Bcl-2蛋白调节凋亡，并成为重要的抗癌药物靶标。我们正在研究源自凋亡的Bcl-2蛋白BH3区域与抗凋亡家族成员的短α-螺旋肽的结合。我们进行结合研究和结构研究，并将其与计算方法相结合，以更好地了解序列如何决定相互作用特异性。 X射线晶体学研究是这项工作的关键组成部分，因为结构提供了有关受体蛋白如何调整以结合一系列不同配体的见解。由于新的结构快照可以为肽或小分子药物设计提供机会，因此这些研究对新的治疗疗法和诊断性的发展具有影响。